🔎 Trials Near Me

Akèy › Dyabèt tip 1 › Kalifòni › San Francisco

Etid klinik pou Dyabèt tip 1 nan San Francisco, CA

14 etid pou Dyabèt tip 1 ap chèche patisipan nan sit nan ak bò kote San Francisco (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Type 1 Diabetes Extension Study

Ap rekriteEtid obsèvasyon
  • UCSF School of Medicine, San Francisco
Laj 8 a 35 · Tout sèks · Mizajou Sep 18, 2026 · NCT02734277

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

Ap rekriteFaz 3
  • University of California San Francisco - Mission Bay- Site Number : 8400011, San Francisco
Laj 1 a 25 · Tout sèks · Mizajou Sep 14, 2026 · NCT07088068

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

Ap rekriteFaz 2
  • University of California San Francisco, San Francisco
Laj 8 a 45 · Tout sèks · Mizajou Sep 8, 2026 · NCT07142252

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

Ap rekriteFaz 1/2
  • UCSF, San Francisco
Laj 9 a 20 · Tout sèks · Mizajou Sep 2, 2026 · NCT07061574

A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

Ap rekriteFaz 3
  • University of California San Francisco, San Francisco
Laj 18 a 65 · Tout sèks · Mizajou Sep 1, 2026 · NCT04786262

HLA Demographics Study in Adults With Type 1 Diabetes

Ap rekriteEtid obsèvasyon
  • University of California, San Francisco, San Francisco
Laj 18 a 55 · Tout sèks · Mizajou Aug 28, 2026 · NCT06860516

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

Ap rekriteFaz 2
  • University of California San Francisco Benioff Children's Hospital, San Francisco
Laj 5 a 40 · Tout sèks · Mizajou Aug 24, 2026 · NCT07187531

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

Ap rekriteFaz 2
  • University of California San Francisco, San Francisco
Laj 6 a 17 · Tout sèks · Mizajou Aug 13, 2026 · NCT07224321

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

Ap rekriteFaz 1
  • University of California - San Francisco, San Francisco
Laj 18 a 55 · Tout sèks · Mizajou Aug 10, 2026 · NCT06919354

Commercial or Open Source Closed Loop Impact on Pregnancy Study

Ap rekriteEtid obsèvasyon
  • University of California, San Francisco, San Francisco
Laj 18 ak plis · Fanm · Mizajou Jul 27, 2026 · NCT06654713

Automated Insulin for Management of Intrapartum Glycemia

Ap rekrite
  • University of California, San Francisco, San Francisco
Laj 18 a 55 · Fanm · Mizajou Jul 13, 2026 · NCT06883344

Registry for Stage 2 Type 1 Diabetes

Ap rekriteEtid obsèvasyon
  • University of California San Francisco - Mission Bay- Site Number : 8400005, San Francisco
Tout laj · Tout sèks · Mizajou Apr 13, 2026 · NCT06481904

A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States

Ap rekriteEtid obsèvasyon
  • Investigational Site, San Francisco
Laj 8 ak plis · Tout sèks · Mizajou Dec 3, 2025 · NCT07260110

TrialNet Pathway to Prevention of T1D

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • University of California San Francisco, San Francisco
Laj 2 a 45 · Tout sèks · Mizajou Jul 1, 2025 · NCT00097292

Etid Dyabèt tip 1 nan lòt vil

Lòt etid nan San Francisco

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.